Controlled release of free doxorubicin from peptide–drug conjugates by drug loading

2014 ◽  
Vol 191 ◽  
pp. 123-130 ◽  
Author(s):  
Zhipeng Chen ◽  
Pengcheng Zhang ◽  
Andrew G. Cheetham ◽  
Jae Hyon Moon ◽  
James W. Moxley ◽  
...  
Author(s):  
Jiaqi Zhou ◽  
Yuanyuan Li ◽  
Wenlong Huang ◽  
Wei Shi ◽  
Hai Qian

2018 ◽  
Vol 29 (2) ◽  
pp. 1806058 ◽  
Author(s):  
Rui Chen ◽  
Jingjing Wang ◽  
Chen Qian ◽  
Yujie Ji ◽  
Chenqi Zhu ◽  
...  

2015 ◽  
Vol 23 (5) ◽  
pp. 907-917 ◽  
Author(s):  
Geoffrey Y Berguig ◽  
Anthony J Convertine ◽  
Shani Frayo ◽  
Hanna B Kern ◽  
Erik Procko ◽  
...  

2018 ◽  
Vol 5 (4) ◽  
pp. 172040 ◽  
Author(s):  
Qin Fan ◽  
Yujie Ji ◽  
Jingjing Wang ◽  
Li Wu ◽  
Weidong Li ◽  
...  

Peptide–drug conjugates (PDCs) as self-assembly prodrugs have the unique and specific features to build one-component nanomedicines. Supramolecular structure based on PDCs could form various morphologies ranging from nanotube, nanofibre, nanobelt to hydrogel. However, the assembly process of PDCs is too complex to predict or control. Herein, we investigated the effects of extrinsic factors on assembly morphology and the possible formation of nanostructures based on PDCs. To this end, we designed a PDC consisting of hydrophobic drug ( S )-ketoprofen (Ket) and valine–glutamic acid dimeric repeats peptide (L-VEVE) to study their assembly behaviour. Our results showed that the critical assembly concentration of Ket-L-VEVE was 0.32 mM in water to form various nanostructures which experienced from micelle, nanorod, nanofibre to nanoribbon. The morphology was influenced by multiple factors including molecular design, assembly time, pH and hydrogen bond inhibitor. On the basis of experimental results, we speculated the possible assembly mechanism of Ket-L-VEVE. The π–π stacking interaction between Ket molecules could serve as an anchor, and hydrogen bonded-induced β-sheets and hydrophilic/hydrophobic balance between L-VEVE peptide play structure-directing role in forming filament-like or nanoribbon morphology. This work provides a new sight to rationally design and precisely control the nanostructure of PDCs based on aromatic fragment.


2021 ◽  
Author(s):  
Bethany M. Cooper ◽  
Jessica Iegre ◽  
Daniel H. O' Donovan ◽  
Maria Ölwegård Halvarsson ◽  
David R. Spring

A tutorial review showcasing how peptide–drug conjugates can offer the versatility needed for a successful drug discovery approach, their problems and future opportunities.


ChemMedChem ◽  
2020 ◽  
Author(s):  
Isabelle Ziffert ◽  
Anette Kaiser ◽  
Paul Hoppenz ◽  
Karin Mörl ◽  
Annette G. Beck‐Sickinger

2016 ◽  
Vol 128 (34) ◽  
pp. 10048-10051 ◽  
Author(s):  
Nick Cox ◽  
James R. Kintzing ◽  
Mark Smith ◽  
Gerald A. Grant ◽  
Jennifer R. Cochran

Sign in / Sign up

Export Citation Format

Share Document